The expression sequence tag is an effective method for screening DNA segments that predict urinary bladder...

Area of Science:

• Genomics and Molecular Biology
• Oncology
• Biomarker Discovery

Background:

• Urothelial cell carcinoma (bladder cancer) diagnosis and prognosis require reliable biomarkers.
• Expression sequence tags (ESTs) offer a method for gene expression profiling.
• Identifying novel predictive markers is crucial for improving patient outcomes.

Purpose of the Study:

• To validate expression sequence tags (ESTs) as a screening tool for DNA segments predicting urothelial cell carcinoma.
• To identify specific ESTs with prognostic value for bladder cancer.
• To evaluate the potential of FTH1 protein as a biomarker.

Main Methods:

• Utilized ESTs to screen for differential gene expression in high-grade and premalignant urothelial cell lines.
• Enrolled eleven patients with varying grades of bladder carcinoma.
• Employed immunohistochemistry and real-time reverse transcription-polymerase chain reaction for validation.

Main Results:

• Apoferritin H subunit (FTH1 protein) showed significantly increased expression in high-grade bladder carcinoma.
• Both immunohistochemistry and real-time RT-PCR confirmed elevated FTH1 expression in high-grade urothelial carcinoma.
• EST screening successfully identified FTH1 as a differentially expressed gene.

Conclusions:

• Expression sequence tags (ESTs) are a valuable tool for identifying potential cancer biomarkers.
• The FTH1 protein is a promising biomarker for predicting the prognosis of bladder carcinoma patients.
• This study validates FTH1 as a predictive marker for urothelial cell carcinoma.